Alert

Recommended Alerts

Sign Up For Alerts

Harmonizing the Common Rule and U.S. Food and Drug Administration Human Subjects Research Regulations

On September 28, 2022, the U.S. Food and Drug Administration issued two Notices of Proposed Rule Making to harmonize FDA’s regulations pertaining to human subjects research and the review of cooperative research by a single institutional review board with those of the Federal Policy for the Protection of Human Subjects. Earlier in September, FDA also issued a draft guidance entitled “Ethical Considerations for Clinical Investigations of Medical Products Involving Children.”

Read More

The SEC's Insider Trading Case Against a Clinical Trial Physician: Lessons For Physicians, Investors, And Public Companies

Practices: Health Care, Hedge Funds, Investment Management, Corporate & Securities Litigation, Government Enforcement / White Collar Crime

Printer-Friendly Version

Cookie Settings